Scott D. Andrew

1.2k total citations
26 papers, 942 citations indexed

About

Scott D. Andrew is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Scott D. Andrew has authored 26 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Scott D. Andrew's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Cancer-related Molecular Pathways (6 papers) and Metal complexes synthesis and properties (4 papers). Scott D. Andrew is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Cancer-related Molecular Pathways (6 papers) and Metal complexes synthesis and properties (4 papers). Scott D. Andrew collaborates with scholars based in Australia, United States and Canada. Scott D. Andrew's co-authors include Bruce G. Robinson, Deborah J. Marsh, Charis Eng, Diana Learoyd, Leigh Delbridge, James R. Johnson, Timothy Kudinha, Gwendolyn L. Gilbert, Peter Anderson and Lois M. Mulligan and has published in prestigious journals such as Applied and Environmental Microbiology, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Scott D. Andrew

26 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott D. Andrew Australia 16 414 334 296 253 144 26 942
Piya Lahiry Canada 10 54 0.1× 378 1.1× 52 0.2× 77 0.3× 122 0.8× 16 642
Nick Makridakis United States 16 369 0.9× 742 2.2× 39 0.1× 109 0.4× 237 1.6× 21 1.2k
Mike R. Wilson United States 16 33 0.1× 462 1.4× 188 0.6× 109 0.4× 73 0.5× 33 904
Daniela De Martino Italy 12 32 0.1× 198 0.6× 87 0.3× 137 0.5× 15 0.1× 15 475
Wagner R. Montor Brazil 11 35 0.1× 357 1.1× 57 0.2× 78 0.3× 70 0.5× 21 605
Mia Tazi United States 14 10 0.0× 448 1.3× 203 0.7× 59 0.2× 14 0.1× 15 870
E. Brouwer Netherlands 14 12 0.0× 252 0.8× 124 0.4× 250 1.0× 55 0.4× 32 792
Kelly Brooks Australia 15 178 0.4× 334 1.0× 103 0.3× 194 0.8× 68 0.5× 26 760
Mario Torrado Spain 16 31 0.1× 448 1.3× 51 0.2× 29 0.1× 85 0.6× 23 712
Arulkumaran Shanmugam United States 9 150 0.4× 357 1.1× 59 0.2× 126 0.5× 109 0.8× 14 659

Countries citing papers authored by Scott D. Andrew

Since Specialization
Citations

This map shows the geographic impact of Scott D. Andrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Andrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Andrew more than expected).

Fields of papers citing papers by Scott D. Andrew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Andrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Andrew. The network helps show where Scott D. Andrew may publish in the future.

Co-authorship network of co-authors of Scott D. Andrew

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Andrew. A scholar is included among the top collaborators of Scott D. Andrew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Andrew. Scott D. Andrew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrew, Scott D., et al.. (2016). Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof. JBIC Journal of Biological Inorganic Chemistry. 21(8). 931–944. 21 indexed citations
2.
3.
4.
Andrew, Scott D., et al.. (2015). Improved cytotoxicity of pyridyl-substituted thiosemicarbazones against MCF-7 when used as metal ionophores. BioMetals. 29(1). 157–170. 8 indexed citations
5.
Andrew, Scott D., et al.. (2015). Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis. Bioorganic & Medicinal Chemistry. 23(13). 3097–3104. 20 indexed citations
6.
Kudinha, Timothy, James R. Johnson, Scott D. Andrew, et al.. (2013). Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls. Clinical Microbiology and Infection. 19(4). E173–E180. 42 indexed citations
7.
Kudinha, Timothy, James R. Johnson, Scott D. Andrew, et al.. (2013). Genotypic and Phenotypic Characterization of Escherichia coli Isolates From Children With Urinary Tract Infection and From Healthy Carriers. The Pediatric Infectious Disease Journal. 32(5). 543–548. 32 indexed citations
8.
Myers, Shirley M., Xuefei Tian, Shu Zhu, et al.. (2009). RET‐mediated gene expression pattern is affected by isoform but not oncogenic mutation. Genes Chromosomes and Cancer. 48(5). 429–440. 17 indexed citations
9.
Patel, Sanjeevkumar R., Richard M. Raymond, Scott D. Andrew, et al.. (2006). Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage. Human Molecular Genetics. 15(23). 3420–3428. 35 indexed citations
10.
Andrew, Scott D., Karen J. Harrison, Sherryl A. Taylor, et al.. (2004). A model for GFRα4 function and a potential modifying role in multiple endocrine neoplasia 2. Oncogene. 24(6). 1091–1097. 9 indexed citations
11.
Andrew, Scott D., Amanda Capes‐Davis, Patric J. D. Delhanty, et al.. (2002). Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway. Gene. 298(1). 9–19. 16 indexed citations
12.
Andrew, Scott D., Patric J. D. Delhanty, Lois M. Mulligan, & Bruce G. Robinson. (2000). Sp1 and Sp3 transactivate the RET proto-oncogene promoter. Gene. 256(1-2). 283–291. 38 indexed citations
13.
Marsh, Deborah J., et al.. (1998). Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma. Human Mutation. 11(S1). S3–S4. 7 indexed citations
14.
EVANS, JEFF, C. P. Bambach, Scott D. Andrew, et al.. (1997). MEN TYPE 2a PRESENTING AS AN INTRA‐ABDOMINAL EMERGENCY. Australian and New Zealand Journal of Surgery. 67(11). 824–826. 5 indexed citations
15.
Gimm, Oliver, Deborah J. Marsh, Scott D. Andrew, et al.. (1997). Germline Dinucleotide Mutation in Codon 883 of theRETProto-Oncogene in Multiple Endocrine Neoplasia Type 2B Without Codon 918 Mutation. The Journal of Clinical Endocrinology & Metabolism. 82(11). 3902–3904. 169 indexed citations
16.
Marsh, Deborah J., Zimu Zheng, Andrew Arnold, et al.. (1997). Mutation Analysis of Glial Cell Line-Derived Neurotrophic Factor, a Ligand for an RET/Coreceptor Complex, in Multiple Endocrine Neoplasia Type 2 and Sporadic Neuroendocrine Tumors. The Journal of Clinical Endocrinology & Metabolism. 82(9). 3025–3028. 22 indexed citations
17.
Marsh, Deborah J., Diana Learoyd, Scott D. Andrew, et al.. (1996). Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma. Clinical Endocrinology. 44(3). 249–257. 211 indexed citations
18.
Marsh, Deborah J., D. McDowall, V.J. Hyland, et al.. (1996). The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families. Clinical Endocrinology. 44(2). 213–220. 63 indexed citations
19.
Marsh, Deborah J., Scott D. Andrew, Charis Eng, et al.. (1996). Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.. PubMed. 56(6). 1241–3. 52 indexed citations
20.
Marsh, Deborah J., Bruce G. Robinson, Scott D. Andrew, et al.. (1994). A Rapid Screening Method for the Detection of Mutations in the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2A and Familial Medullary Thyroid Carcinoma Families. Genomics. 23(2). 477–479. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piya Lahiry Breakdown of academic impact, for papers by Nick Makridakis Breakdown of academic impact, for papers by Mike R. Wilson Breakdown of academic impact, for papers by Daniela De Martino Breakdown of academic impact, for papers by Wagner R. Montor Breakdown of academic impact, for papers by Mia Tazi Breakdown of academic impact, for papers by E. Brouwer Breakdown of academic impact, for papers by Kelly Brooks Breakdown of academic impact, for papers by Mario Torrado Breakdown of academic impact, for papers by Arulkumaran Shanmugam
Rankless by CCL
2026